Brown Robert E. JR's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Dec 2, 2022
- Accession no.
- 0001104659-22-124079
- Filed
- Dec 2, 2022, 4:00 PM ET
- Trade date
- Dec 1, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $7.70M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brown Robert E. JRCIK 0001579672 | Director |
| Meridian Venture Partners II LPCIK 0001109507 | 10% Owner |
| Meridian Venture Partners II, Co.CIK 0001580169 | 10% Owner |
| Meridian Venture Partners II GP, L.P.CIK 0001580170 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Common Stock | SSaleDisposed | −200,000 | $38.50 | −$7,700,000 | 2,019,259 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.